Our individual genomes make us unique, and contribute to both rare and common disease.

In genomic testing, it’s vital to distinguish the clinically relevant, disease-causing variant from its background normal genomic variation in order to safely manage patients.

Get variant interpretation training for effectively managing patients

This course is designed to educate health professionals involved in the variant journey from the laboratory to the patient.

You’ll explore the fundamental principles of variant interpretation and review the American College of Clinical Genetics and Genomic (ACMG) and The Association for Clinical Genomic Science (AGCS) guidelines. You will also take a detailed look at the tools available to aid genomic variant interpretation.

Study the ACMG and ACGS guidelines in theory and practice

The ACMG and ACGS guidelines were developed to promote consistency in the tools used to classify a genomic variant as pathogenic, likely pathogenic, likely benign, benign, or uncertain.

You’ll explore how the ACMG evaluated each of the tools and applied a weighting, as well as the algorithm developed to combine the evidence from each of these tools.

You’ll be encouraged to apply your learning through workshopped examples that illustrate both the strengths and weaknesses of the ACMG tools and framework.

This course is part of a series with Interpreting Genomic Variation: Inherited Cancer Susceptibility.